|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/755 | |
| A61K 38/36 | |||
| A61K 38/37 | |||
| A61P 7/04 |
| (11) | Number of the document | 3152230 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15732554.9 |
| Date of filing the European patent application | 2015-06-08 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/062730 |
| Date | 2015-06-08 |
| (87) | Number | WO 2015/185758 |
| Date | 2015-12-10 |
| (30) | Number | Date | Country code |
| 14171579 | 2014-06-06 | EP |
| (72) |
KANNICHT, Christoph, DE
SOLECKA, Barbara, DE
KOHLA, Guido, DE
WINGE, Stefan, SE
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES |
| PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES |